Instil Bio, Inc. (TIL)

NASDAQ: TIL · IEX Real-Time Price · USD
-0.007 (-1.72%)
Sep 28, 2023, 10:30 AM EDT - Market open

Total Valuation

Instil Bio has a market cap or net worth of $52.72 million. The enterprise value is -$62.84 million.

Market Cap 52.72M
Enterprise Value -62.84M

Important Dates

The next estimated earnings date is Monday, November 13, 2023, before market open.

Earnings Date Nov 13, 2023
Ex-Dividend Date n/a

Share Statistics

Instil Bio has 130.08 million shares outstanding. The number of shares has increased by 0.55% in one year.

Shares Outstanding 130.08M
Shares Change (YoY) +0.55%
Shares Change (QoQ) n/a
Owned by Insiders (%) 6.84%
Owned by Institutions (%) 71.53%
Float 68.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.18
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.00, with a Debt / Equity ratio of 0.29.

Current Ratio 12.00
Quick Ratio n/a
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -66.23

Financial Efficiency

Return on equity (ROE) is -53.80% and return on invested capital (ROIC) is -38.90%.

Return on Equity (ROE) -53.80%
Return on Assets (ROA) -40.20%
Return on Capital (ROIC) -38.90%
Revenue Per Employee n/a
Profits Per Employee -$967,698
Employee Count 192
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -976,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -91.37% in the last 52 weeks. The beta is 1.26, so Instil Bio's price volatility has been higher than the market average.

Beta (1Y) 1.26
52-Week Price Change -91.37%
50-Day Moving Average 0.49
200-Day Moving Average 0.62
Relative Strength Index (RSI) 40.20
Average Volume (30 Days) 365,139

Short Selling Information

The latest short interest is 758,401, so 0.58% of the outstanding shares have been sold short.

Short Interest 758,401
Short Previous Month 809,620
Short % of Shares Out 0.58%
Short % of Float 1.11%
Short Ratio (days to cover) 3.60

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -192.88M
Pretax Income -186.77M
Net Income -185.80M
EBITDA -176.14M
EBIT -184.00M
Earnings Per Share (EPS) -$1.42
Full Income Statement

Balance Sheet

The company has $201.70 million in cash and $85.21 million in debt, giving a net cash position of $116.49 million or $0.90 per share.

Cash & Cash Equivalents 201.70M
Total Debt 85.21M
Net Cash 116.49M
Net Cash Per Share $0.90
Equity / Book Value 296.52M
Book Value Per Share 2.28
Working Capital 202.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$132.08 million and capital expenditures -$53.66 million, giving a free cash flow of -$185.73 million.

Operating Cash Flow -132.08M
Capital Expenditures -53.66M
Free Cash Flow -185.73M
FCF Per Share -$1.43
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -346.35%
FCF Yield -346.23%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.55%
Shareholder Yield -0.55%

Analyst Forecast

The average price target for Instil Bio is $6.00, which is 1,380.39% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 1,380.39%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a